Arteris Inc

Under a Stage 4 decline and persistent lower-high/lower-low structure, the medium-term bias is bearish. However, extreme oversold conditions and support at the 200-day SMA make immediate sell execution unattractive. We will defer selling and look to trim into a relief rally toward the falling 9- and 20-day EMA zone for a clearer rejection.

• ↑Q2 revenue $24.1M (+46% YoY) with guidance lifted to $95–98M
• ↑Annual contract value plus royalties at $99.5M (up 44% YoY)
• ↓Q2 non-GAAP operating loss of $4.6M driven by high payroll taxes